As per the letter enclosed.
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwal's Eye Hospital reported its Q1 FY26 results with revenue from operations at ₹116.92 crore, up about 17% year-on-year from ₹100.02 crore in Q1 FY25. Net profit after tax rose to ₹17.26 crore from ₹14.11 crore, a growth of roughly 22% YoY. EBITDA grew to ₹37.93 crore from ₹31.81 crore, and EPS stood at ₹36.72 vs ₹30.02 in the same quarter last year. Profit before tax came in at ₹23.19 crore vs ₹18.91 crore. The statutory auditor Deloitte Haskins & Sells issued an unmodified limited review report with no qualifications or concerns raised.
Strong, broad-based growth across revenue, profit, and EBITDA suggests healthy operating momentum and could be viewed positively by investors. The clean auditor report with no qualifications adds further comfort on the numbers.